SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Oscar Health, Inc. of Class Action Lawsuit and Upcoming Deadline – OSCR

NEW YORK, July 09, 2022 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Oscar Health, Inc. ("Oscar" or the "Company") (NYSE:OSCR ) and certain of its officers. The class action, filed in the United States District Court for the Southern District of New York, and docketed under 22-cv-04103, is on behalf of a class consisting of all persons and entities other than Defendants that purchased or otherwise acquired Oscar Class A common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with the Company's March 2021 initial public offering ("IPO" or the "Offering"). Plaintiff pursues claims against under the Securities Act of 1933 (the "Securities Act"). If you are a shareholder who purchased or otherwise acquired Oscar Class A common stock, pursuant and/or traceable to the company's IPO, you have until July 11, 2022 to ask the Court to appoint you as Lead Plaintiff for the class. A copy of the Complaint can be obtained at www.pomerantzlaw.com . To discuss this action, contact Robert S. Willoughby at newaction@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. [Click here for information about joining the class action] Oscar is a health insurance company that claims to be the first such company "built around a full stack technology platform" which will "allow [Oscar] to continue to innovate like a ... Full story available on Benzinga.com